Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 171

1.

Socket Reconstruction With Bleomycin, Gentamicin, and Gelatin Sponges Following Eyelid-Sparing Orbital Exenteration for a Colobomatous Macrocyst in an Infant.

Michelson SJ, Ciongoli MR, Elner VM, Kahana A.

Ophthalmic Plast Reconstr Surg. 2018 Nov/Dec;34(6):e201-e203. doi: 10.1097/IOP.0000000000001246.

PMID:
30320716
2.

Development and characterization of an aged onset model of Alzheimer's disease in Drosophila melanogaster.

Mhatre SD, Michelson SJ, Gomes J, Tabb LP, Saunders AJ, Marenda DR.

Exp Neurol. 2014 Nov;261:772-81. doi: 10.1016/j.expneurol.2014.08.021. Epub 2014 Aug 27.

PMID:
25173219
3.
4.

Characterization of a Drosophila Alzheimer's disease model: pharmacological rescue of cognitive defects.

Chakraborty R, Vepuri V, Mhatre SD, Paddock BE, Miller S, Michelson SJ, Delvadia R, Desai A, Vinokur M, Melicharek DJ, Utreja S, Khandelwal P, Ansaloni S, Goldstein LE, Moir RD, Lee JC, Tabb LP, Saunders AJ, Marenda DR.

PLoS One. 2011;6(6):e20799. doi: 10.1371/journal.pone.0020799. Epub 2011 Jun 6.

5.

The role of values-consistent behavior in generalized anxiety disorder.

Michelson SE, Lee JK, Orsillo SM, Roemer L.

Depress Anxiety. 2011 May;28(5):358-66. doi: 10.1002/da.20793. Epub 2011 Feb 9.

6.

Characterizing eating disorders in a personality disorders sample.

Chen EY, McCloskey MS, Michelson S, Gordon KH, Coccaro E.

Psychiatry Res. 2011 Feb 28;185(3):427-32. doi: 10.1016/j.psychres.2010.07.002. Epub 2010 Jul 27.

7.

Behavioral aspects of HIV care: adherence, depression, substance use, and HIV-transmission behaviors.

Berg CJ, Michelson SE, Safren SA.

Infect Dis Clin North Am. 2007 Mar;21(1):181-200, x. Review.

PMID:
17502235
8.

The future of predictive biosimulation in drug discovery.

Michelson S, Cole M.

Expert Opin Drug Discov. 2007 Apr;2(4):515-23. doi: 10.1517/17460441.2.4.515.

PMID:
23484759
9.

In silico prediction of clinical efficacy.

Michelson S, Sehgal A, Friedrich C.

Curr Opin Biotechnol. 2006 Dec;17(6):666-70. Epub 2006 Oct 12. Review.

PMID:
17046236
10.

Cambodian founder effect for spinocerebellar ataxia type 3 (Machado-Joseph disease).

Jayadev S, Michelson S, Lipe H, Bird T.

J Neurol Sci. 2006 Dec 1;250(1-2):110-3. Epub 2006 Oct 5.

PMID:
17027034
11.

The impact of systems biology and biosimulation on drug discovery and development.

Michelson S.

Mol Biosyst. 2006 Jun;2(6-7):288-91. Epub 2006 May 18.

PMID:
16880946
12.

Diagnosis and treatment of cytomegalovirus iridocyclitis without retinal necrosis.

de Schryver I, Rozenberg F, Cassoux N, Michelson S, Kestelyn P, Lehoang P, Davis JL, Bodaghi B.

Br J Ophthalmol. 2006 Jul;90(7):852-5. Epub 2006 Apr 5.

13.

Double trouble in hereditary neuropathy: concomitant mutations in the PMP-22 gene and another gene produce novel phenotypes.

Hodapp JA, Carter GT, Lipe HP, Michelson SJ, Kraft GH, Bird TD.

Arch Neurol. 2006 Jan;63(1):112-7. Erratum in: Arch Neurol. 2006 Apr;63(4):501.

PMID:
16401743
14.

The human cytomegalovirus-encoded chemokine receptor US28 induces caspase-dependent apoptosis.

Pleskoff O, Casarosa P, Verneuil L, Ainoun F, Beisser P, Smit M, Leurs R, Schneider P, Michelson S, Ameisen JC.

FEBS J. 2005 Aug;272(16):4163-77.

15.

Assessing the impact of predictive biosimulation on drug discovery and development.

Michelson S.

J Bioinform Comput Biol. 2003 Apr;1(1):169-77.

PMID:
15290786
16.

Use of a lentiviral vector encoding a HCMV-chimeric IE1-pp65 protein for epitope identification in HLA-Transgenic mice and for ex vivo stimulation and expansion of CD8(+) cytotoxic T cells from human peripheral blood cells.

Rohrlich PS, Cardinaud S, Lulè J, Montero-Julian FA, Prodhomme V, Firat H, Davignon JL, Perret E, Monseaux S, Necker A, Michelson S, Lemonnier FA, Charneau P, Davrinche C.

Hum Immunol. 2004 May;65(5):514-22.

PMID:
15172452
17.

Consequences of human cytomegalovirus mimicry.

Michelson S.

Hum Immunol. 2004 May;65(5):465-75. Review.

PMID:
15172446
18.

Unusual tumors associated with the hereditary nonpolyposis colorectal cancer syndrome.

Broaddus RR, Lynch PM, Lu KH, Luthra R, Michelson SJ.

Mod Pathol. 2004 Aug;17(8):981-9.

19.

Orally efficacious NR2B-selective NMDA receptor antagonists.

Claiborne CF, McCauley JA, Libby BE, Curtis NR, Diggle HJ, Kulagowski JJ, Michelson SR, Anderson KD, Claremon DA, Freidinger RM, Bednar RA, Mosser SD, Gaul SL, Connolly TM, Condra CL, Bednar B, Stump GL, Lynch JJ, Macaulay A, Wafford KA, Koblan KS, Liverton NJ.

Bioorg Med Chem Lett. 2003 Feb 24;13(4):697-700.

PMID:
12639561
20.

Design and synthesis of 8-hydroxy-[1,6]naphthyridines as novel inhibitors of HIV-1 integrase in vitro and in infected cells.

Zhuang L, Wai JS, Embrey MW, Fisher TE, Egbertson MS, Payne LS, Guare JP Jr, Vacca JP, Hazuda DJ, Felock PJ, Wolfe AL, Stillmock KA, Witmer MV, Moyer G, Schleif WA, Gabryelski LJ, Leonard YM, Lynch JJ Jr, Michelson SR, Young SD.

J Med Chem. 2003 Feb 13;46(4):453-6.

PMID:
12570367
21.

Viral chemokine receptors and chemokines in human cytomegalovirus trafficking and interaction with the immune system. CMV chemokine receptors.

Beisser PS, Goh CS, Cohen FE, Michelson S.

Curr Top Microbiol Immunol. 2002;269:203-34. Review.

PMID:
12224510
22.

2-Chloro-3-pyridin-3-yl-5,6,7,8-tetrahydroindolizine-1-carboxamide (CMV423), a new lead compound for the treatment of human cytomegalovirus infections.

Snoeck R, Andrei G, Bodaghi B, Lagneaux L, Daelemans D, de Clercq E, Neyts J, Schols D, Naesens L, Michelson S, Bron D, Otto MJ, Bousseau A, Nemecek C, Roy C.

Antiviral Res. 2002 Sep;55(3):413-24.

PMID:
12206879
23.

Differentiation-dependent redistribution of heparan sulfate in epithelial intestinal Caco-2 cells leads to basolateral entry of cytomegalovirus.

Esclatine A, Bellon A, Michelson S, Servin AL, Quéro AM, Géniteau-Legendre M.

Virology. 2001 Oct 10;289(1):23-33.

24.

Human cytomegalovirus infection of bone marrow myofibroblasts enhances myeloid progenitor adhesion and elicits viral transmission.

Michelson S, Rohrlich P, Beisser P, Laurent L, Perret E, Prévost MC, Monchatre E, Duval M, Marolleau JP, Charbord P.

Microbes Infect. 2001 Oct;3(12):1005-13.

PMID:
11580987
25.

Human cytomegalovirus chemokine receptor gene US28 is transcribed in latently infected THP-1 monocytes.

Beisser PS, Laurent L, Virelizier JL, Michelson S.

J Virol. 2001 Jul;75(13):5949-57.

26.

A canarypox vector-expressing cytomegalovirus (CMV) phosphoprotein 65 induces long-lasting cytotoxic T cell responses in human CMV-seronegative subjects.

Berencsi K, Gyulai Z, Gönczöl E, Pincus S, Cox WI, Michelson S, Kari L, Meric C, Cadoz M, Zahradnik J, Starr S, Plotkin S.

J Infect Dis. 2001 Apr 15;183(8):1171-9. Epub 2001 Mar 13.

PMID:
11262198
27.
28.

High efficient production of Pr55(gag) virus-like particles expressing multiple HIV-1 epitopes, including a gp120 protein derived from an Ugandan HIV-1 isolate of subtype A.

Buonaguro L, Buonaguro FM, Tornesello ML, Mantas D, Beth-Giraldo E, Wagner R, Michelson S, Prevost MC, Wolf H, Giraldo G.

Antiviral Res. 2001 Jan;49(1):35-47.

PMID:
11166859
29.

Acyclovir-resistant bilateral keratitis associated with mutations in the HSV-1 thymidine kinase gene.

Bodaghi B, Mougin C, Michelson S, Agut H, Dighiero P, Offret H, Frau E.

Exp Eye Res. 2000 Oct;71(4):353-9.

PMID:
10995556
30.

Identification of MK-944a: a second clinical candidate from the hydroxylaminepentanamide isostere series of HIV protease inhibitors.

Dorsey BD, McDonough C, McDaniel SL, Levin RB, Newton CL, Hoffman JM, Darke PL, Zugay-Murphy JA, Emini EA, Schleif WA, Olsen DB, Stahlhut MW, Rutkowski CA, Kuo LC, Lin JH, Chen IW, Michelson SR, Holloway MK, Huff JR, Vacca JP.

J Med Chem. 2000 Sep 7;43(18):3386-99.

PMID:
10978186
31.

Human cytomegalovirus escape from immune detection.

Michelson S.

Intervirology. 1999;42(5-6):301-7. Review.

PMID:
10702710
32.

Cytomegalovirus: virological facts for clinicians.

Bodaghi B, Michelson S.

Ocul Immunol Inflamm. 1999 Dec;7(3-4):133-7. Review.

PMID:
10611720
33.

Entry of human cytomegalovirus into retinal pigment epithelial and endothelial cells by endocytosis.

Bodaghi B, Slobbe-van Drunen ME, Topilko A, Perret E, Vossen RC, van Dam-Mieras MC, Zipeto D, Virelizier JL, LeHoang P, Bruggeman CA, Michelson S.

Invest Ophthalmol Vis Sci. 1999 Oct;40(11):2598-607.

PMID:
10509655
34.

Managed care of children with special health care needs: the ABC Program.

Grossman LK, Rich LN, Michelson S, Hagerty G.

Clin Pediatr (Phila). 1999 Mar;38(3):153-60.

PMID:
10349080
35.

Nonpeptide oxytocin antagonists: analogs of L-371,257 with improved potency.

Williams PD, Bock MG, Evans BE, Freidinger RM, Gallicchio SN, Guidotti MT, Jacobson MA, Kuo MS, Levy MR, Lis EV, Michelson SR, Pawluczyk JM, Perlow DS, Pettibone DJ, Quigley AG, Reiss DR, Salvatore C, Stauffer KJ, Woyden CJ.

Bioorg Med Chem Lett. 1999 May 3;9(9):1311-6.

PMID:
10340620
36.

Implication of gammadelta T cells in the human immune response to cytomegalovirus.

Déchanet J, Merville P, Lim A, Retière C, Pitard V, Lafarge X, Michelson S, Méric C, Hallet MM, Kourilsky P, Potaux L, Bonneville M, Moreau JF.

J Clin Invest. 1999 May 15;103(10):1437-49.

37.

Kinetics of transcription of human cytomegalovirus chemokine receptor US28 in different cell types.

Zipeto D, Bodaghi B, Laurent L, Virelizier JL, Michelson S.

J Gen Virol. 1999 Mar;80 ( Pt 3):543-7.

PMID:
10091991
38.
39.

Chemokine sequestration by viral chemoreceptors as a novel viral escape strategy: withdrawal of chemokines from the environment of cytomegalovirus-infected cells.

Bodaghi B, Jones TR, Zipeto D, Vita C, Sun L, Laurent L, Arenzana-Seisdedos F, Virelizier JL, Michelson S.

J Exp Med. 1998 Sep 7;188(5):855-66.

40.

Development of orally active oxytocin antagonists: studies on 1-(1-[4-[1-(2-methyl-1-oxidopyridin-3-ylmethyl)piperidin-4-yloxy]-2- methoxybenzoyl]piperidin-4-yl)-1,4-dihydrobenz[d][1,3]oxazin-2-one (L-372,662) and related pyridines.

Bell IM, Erb JM, Freidinger RM, Gallicchio SN, Guare JP, Guidotti MT, Halpin RA, Hobbs DW, Homnick CF, Kuo MS, Lis EV, Mathre DJ, Michelson SR, Pawluczyk JM, Pettibone DJ, Reiss DR, Vickers S, Williams PD, Woyden CJ.

J Med Chem. 1998 Jun 4;41(12):2146-63.

PMID:
9622556
41.

Modulation of RANTES production by human cytomegalovirus infection of fibroblasts.

Michelson S, Dal Monte P, Zipeto D, Bodaghi B, Laurent L, Oberlin E, Arenzana-Seisdedos F, Virelizier JL, Landini MP.

J Virol. 1997 Sep;71(9):6495-500.

42.

TAR and Sp1-independent transactivation of HIV long terminal repeat by the Tat protein in the presence of human cytomegalovirus IE1/IE2.

Dal Monte P, Landini MP, Sinclair J, Virelizier JL, Michelson S.

AIDS. 1997 Mar;11(3):297-303.

PMID:
9147420
43.

Positive feedback and angiogenesis in tumor growth control.

Michelson S, Leith JT.

Bull Math Biol. 1997 Mar;59(2):233-54.

PMID:
9116601
44.

Interaction of human cytomegalovirus with monocytes/macrophages: a love-hate relationship.

Michelson S.

Pathol Biol (Paris). 1997 Feb;45(2):146-58. Review.

PMID:
9247037
45.

Preventing skin breakdown: nursing practices, costs, and outcomes.

Bostrom J, Mechanic J, Lazar N, Michelson S, Grant L, Nomura L.

Appl Nurs Res. 1996 Nov;9(4):184-8.

PMID:
8961575
46.

Dielectric properties of supercooled cryoprotectant agents.

Michelson SC, Evans S.

Phys Med Biol. 1996 Oct;41(10):2053-66.

PMID:
8912380
47.

Expression of human cytomegalovirus ppUL83 (pp65) in a stable cell line and its association with metaphase chromosomes.

Dal Monte P, Bessia C, Landini MP, Michelson S.

J Gen Virol. 1996 Oct;77 ( Pt 10):2591-6.

PMID:
8887495
48.
49.

Cytomegalovirus-induced alveolar hemorrhage in patients with AIDS: a new clinical entity?

Herry I, Cadranel J, Antoine M, Meharzi J, Michelson S, Parrot A, Rozenbaum W, Mayaud C.

Clin Infect Dis. 1996 Apr;22(4):616-20.

PMID:
8729198
50.

Stably expressed antisense RNA to cytomegalovirus UL83 inhibits viral replication.

Dal Monte P, Bessia C, Ripalti A, Landini MP, Topilko A, Plachter B, Virelizier JL, Michelson S.

J Virol. 1996 Apr;70(4):2086-94.

Supplemental Content

Loading ...
Support Center